On May 13, 2011
At Teva, Bigger Isn’t Better: Why Acquisitions Are Ruining a Once Great Company
As the company approaches Big Pharma size it has taken on Big Pharma’s problems: Its operating costs are growing faster than it revenues and showing some signs of eroding its net income.
No tags for this post.
0 Comments